Søren Bols Pedersen

Title: Søren Bols Pedersen: Innovator in Pharmaceutical Formulations

Introduction

Søren Bols Pedersen is a notable inventor based in Hvidovre, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of formulations that exhibit anti-ulcer activity. His work is characterized by a focus on innovative solutions that address critical health issues.

Latest Patents

Søren Bols Pedersen holds a patent for a pharmaceutical formulation comprising a 2-[(2-pyridinyl)methyl] sulfinyl benzimidazole, which has demonstrated anti-ulcer activity. The patent details an oral pharmaceutical formulation that includes granules with an inert core, coated with a layer containing the active ingredient, a disintegrant, and a surfactant. This formulation utilizes a melt coating technique to prepare the benzimidazole-containing layer, showcasing his expertise in pharmaceutical technology.

Career Highlights

Throughout his career, Søren has been associated with A/S Gea Farmaceutisk Fabrik, where he has contributed to various projects aimed at enhancing drug formulations. His innovative approach has led to advancements in the pharmaceutical industry, particularly in the area of oral medications.

Collaborations

Søren has worked alongside talented colleagues such as Kristian Lund Henriksen and Helle Kann. Their collaborative efforts have further enriched the research and development environment at A/S Gea Farmaceutisk Fabrik.

Conclusion

Søren Bols Pedersen's contributions to pharmaceutical formulations highlight his role as an innovator in the field. His patent for a novel anti-ulcer formulation exemplifies the impact of his work on improving health outcomes.